Top

International Orthopaedics

Published in:

01-05-2021 | Phlebothrombosis | Letter to the Editor

Letter to the editor on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial”

Authors: Dongfeng Zhang, Hao Wu, Qingquan Kong

Published in: International Orthopaedics | Issue 5/2021

Excerpt

Dear Editor, …

Zhang L, Li Y, Liu D et al (2020) Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial. Int Orthop 44(10):2079–2087. https://doi.org/10.1007/s00264-020-04699-3CrossRefPubMed

Xie J, Zhang S, Chen G et al (2019) Optimal route for administering tranexamic acid in primary unilateral total hip arthroplasty: results from a multicenter cohort study. Brit J Clin Pharmaco 85(9):2089–2097. https://doi.org/10.1111/bcp.14018CrossRef

Kim KT, Kim CK, Kim YC et al (2017) The effectiveness of low-dose and high-dose tranexamic acid in posterior lumbar interbody fusion: a double-blinded, placebo-controlled randomized study. Eur Spine J 26(11):2851–2857. https://doi.org/10.1007/s00586-017-5230-4CrossRefPubMed

Yuan QM, Zhao ZH, Xu BS (2017) Efficacy and safety of tranexamic acid in reducing blood loss in scoliosis surgery: a systematic review and meta-analysis. Eur Spine J 26(1):131–139. https://doi.org/10.1007/s00586-016-4899-0CrossRefPubMed

Bohl DD, Webb ML, Lukasiewicz AM et al (2015) Timing of complications after spinal fusion surgery. SPINE. 40(19):1527–1535. https://doi.org/10.1097/BRS.0000000000001073CrossRefPubMed

Title: Letter to the editor on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial”
Authors: Dongfeng Zhang
Hao Wu
Qingquan Kong
Publication date: 01-05-2021
Publisher: Springer Berlin Heidelberg
Keywords: Phlebothrombosis
Tranexamic Acid
Thrombosis
Rivaroxaban
Published in: International Orthopaedics / Issue 5/2021
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-021-04988-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Letter to the editor on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial”

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2021

No reduced patellar loading with latest-generation cruciate-retaining total knee arthroplasty—a comparative study of Attune and Press-Fit Condylar®

Modified Judet’s quadricepsplasty plus patellar traction for knee stiffness after femoral fracture surgery

Long dorsal “Y-shaped” plate for distal diaphyseal humeral fractures

Arthroscopic evaluation for tibial plateau fractures on the incidence and types of cruciate ligamentous injuries following closed reduction and internal fixation

Self-quarantine programme and pre-operative SARS-CoV-2 PCR screening for orthopaedic elective surgery: experience from Japan

Long-term follow-up of Bologna-Oxford (BOX) total ankle arthroplasty